Epidemiology of myasthenia gravis in northwestern sardinia

Neuroepidemiology

Volumn 16, Issue 4, 1997, Pages 199-206

  Aiello, I ^a   Pastorino, M ^a   Sotgiu, S ^a   Pirastm, M I ^a   Sail, G F ^a   Sanna, G ^a   Rosati, G ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

Epidemiology; Genetic susceptibility; Myasthenia gravis; Sardinia

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GENETIC SUSCEPTIBILITY; HUMAN; INFANT; ITALY; MALE; MYASTHENIA GRAVIS; PREVALENCE; RISK ASSESSMENT;

EID: 0030838677     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000109688     Document Type: Article

References (24)

1. Menozzi P. Piazza A. Cavalli-Sforza LL: Synthetic maps of human gene frequencies in Europeans. Science 1978;201:786-792.
2. Piazza A. Mayr WR, Contu L, Amoroso A, Borelli I, Curtoni ES, Marcello C, Moroni A. Olivetti E, Richiardi P, et al: Genetic and population structure of four Sardinian villages. Ann Hum Genet 1985;45: 47-63.
3. Piazza A, Cappello N, Olivetti E, Rendine S: A genetic history of Italy. Ann Hum Genet 1988;52:203-213.
4. Rosati G: Descriptive epidemiology of multiple sclerosis in Europe in the 1980s: A critical overview. Ann Neurol 1994;36(suppl 2): SI64-S174.
5. Cucca F, Congia M, Trowsdale J, Powis SH: Insulin-dependent diabetes mellitus and the major histocompatibility complex peptide transporters TAPI and TAP2: No association in a population with a high disease incidence. Tissue Antigens 1994;44:234-240.
6. Oosterhuis HJGH: Myasthenia gravis. Clinical Neurology and Neurosurgery Monographs. Edinburgh, Churchill-Livingstone, 1984, pp 142-158.
7. Sanders DB: Electrodiagnosis in myasthenia gravis. Recent techniques; in Alburquerque EX, Etde-frawi AT (eds): Myasthenia gravis. London, Chapman & Hall, 1983, pp 275-296.
8. Mastaglia FL, Black JL, Collins DWK, Dawkins RL: Saccadic velocities in diagnosis of myasthenia gravis. Lancet 1977;Vol ii:83.
9. Osserman K.E, Genkins G: Studies in Myasthenia gravis: Review of a twenty-year experience in over 1200 patients. Mt Sinai J Med 1971;38: 497-537.
10. Treves TA, Rocca WA, Meneghini F: Epidemiology of myasthenia gravis; in: Neuroepidemiology: A Tribute to Bruce Schoenberg. Boca Raton, CRC Press, 1991, pp297-309.
11. D'Alessandro R, Granieri E, Bcnas-si G, Tola MR, Casmiro M, Maz-zanti B, Gamberini G, Caniatti L: Comparative study on the prevalence of myasthenia gravis in the provinces of Bologna and Ferrara, Italy. Acta Neurol Scand 1991;83: 83-88.
12. Giagheddu M, Puggioni G, Sanna G, Tamburini G, Marrosu F, Ra-chele MG, Murgia B, Rosati G: Epidemiological study of myasthenia gravis in Sardinia, Italy (1958-1986). Acta Neurol Scand 1989;79: 326-333.
13. Christensen PB, Jensen TS, Tsiro-poulos I, Sorensen T, Kjar M, Hojer-Pedersen E, Rasmussen MJK, Lehfeldt E, de Fine Olivarius B: Incidence and prevalence of myasthenia gravis in western Denmark: 1975 to 1989. Neurology 1993;43: 1779-1783.
14. Storm-Mathisen A: Epidemiology of myasthenia gravis in Norway. Acta Neurol Scand 1984;70:274-284.
15. Sadovnick AD, Ebers GC: Epidemiology of multiple sclerosis: A critical overview. Can J Neurol Sci 1993;20: 17-29.
16. Williams DR: Epidemiological and geographic factors in diabetes. Eye 1993;7:202-204.
17. Compston A: Genetic susceptibility to multiple sclerosis; in Mattews WB, Compston A, Allen IV, Martin CN (eds): McAlpine’s Multiple Sclerosis, ed 2. Edinburgh, Churchill-Livingstone, 1991, pp 301-319.
18. Haegert DG, Marrosu MG: Genetic susceptibility to multiple sclerosis. Ann Neurol 1994;36(suppl 2):S204-S210.
19. Kurtzke JF: Epidemiology of myasthenia gravis; in Adv Neurol, vol 19. New York. Raven Press, 1978, pp 545-566.
20. Marrosu MG, Murru MR, Costa G, Vaccargiu S: Polimorfismi del tumor necrosis factor alfa nella sclero-si multipla: studio di associazione con HLA di classe II in una popola-zione sarda. 6th National Congress of Neuroimmunology, National Society, Bergamo (Italy), November 2-4, 1995, abstr 76.
21. Kuks JB, Lems SP, Oosterhuis HJ: HLA type is not indicative for the effect of thymectomy in myasthenia gravis. J Neuroimmunol 1992;36: 217-224.
22. Demaine A, Willcox N, Janer M, Welsh K, Newsom Davis J: Immunoglobulin heavy chain gene association in myasthenia gravis: New evidence for disease heterogeneity. J Neurol 1992;239:53-56.
23. Mazzclla M, Cotellessa M, Bonassi S, Mulas R, Caratozzolo A, Gaber S, Romano C: Incidence of type 1 diabetes in the Liguria Region, Italy. Results of a prospective study in a 0-to 14-year age group. Diabetes Care 1994;17:1193-1196.
24. Fava D, Leslie RD, Pozzilli P: Relationship between dairy product consumption and incidence of 1DDM in childhood in Italy. Diabetes Care 1994;17:1488-1490.